查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
分子诊断市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按疾病领域、技术、产品和服务、最终用户和地理位置
市场调查报告书
商品编码
1362395

分子诊断市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围：按疾病领域、技术、产品和服务、最终用户和地理位置

Molecular Diagnostics Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Area, Technology, Product & Services, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 272 Pages | 订单完成后即时交付

价格

分子诊断市场规模预计将从2022年的1817387万美元增至2030年的4587565万美元；预计 2022 年至 2030 年复合年增长率为 12.3%。该报告强调了市场的普遍趋势以及驱动和阻碍分子诊断市场成长的因素。市场的成长归因于新产品的开发、即时检测需求的增加以及相关疾病盛行率的飙升。然而，与分子测试相关的限制阻碍了市场的成长。

个人化医疗中的分子诊断促进未来几年分子诊断市场的成长

随着高通量技术的进步，基因组研究变得更加方便且具有成本效益。分子诊断在临床实验室中变得越来越不可或缺，因为这些试剂盒和测试可提供快速的检测结果，而传统测试在某些情况下还涉及在实验室条件下培养微生物。使用精准医学，根据每位患者独特的基因组成、生活方式和环境，为其量身定制医疗治疗和干预措施。分子诊断在这种方法中发挥重要作用，因为它能够识别影响患者治疗相关决策的特定生物标记、基因突变和基因表现模式。药物开发越来越依赖分子诊断。广泛的分子影像技术用于筛检、检测、诊断、治疗和评估异质性；制定进步计划；检查分子特征；并监测患者的治疗结果。此外，分子影像可以帮助检测微小肿瘤并评估其活动，为肿瘤学个人化医疗、研究、临床试验和医疗实践的发展和扩展做出重大贡献。高通量基因分型平台可用于检测临床样本中的遗传畸变，次世代定序可用于识别所有类型的致癌变化。将这些技术引入临床实践将能够识别每个患者的分子标靶，并有助于追踪疾病的分子进展。透过这些方法，癌症患者将能够接受个人化医疗。因此，随着技术的不断发展，分子诊断市场似乎有着光明的前景。

与分子测试相关的限制阻碍了市场成长

分子检测的结果取决于采样和检测过程、技术人员的技能等，这可能会导致检测结果的变化。此外，有些测试程序需要更长的时间才能产生结果。很多时候，检测试剂盒可能会显示假阳性或阴性结果。因此，与分子测试相关的不确定性阻碍了它们的采用，特别是在危及生命的疾病的诊断和治疗方面。对现场检测的认识有限，特别是在发展中国家和不发达国家，也阻碍了市场的成长。此外，癌症和病毒感染等适应症的分子检测成本以及供应短缺正在阻碍分子诊断市场的发展。

分子诊断市场，依疾病领域洞察

根据疾病领域，分子诊断市场分为肿瘤学、传染病、基因检测、心臟病、免疫系统疾病等。

传染病领域在 2022 年占据最大的市场份额。然而，肿瘤领域预计在预测期内复合年增长率最高，达到 12.6%。肿瘤分子诊断是暴露遗传物质、蛋白质、相关分子并基于传递肿瘤讯息的 DNA、RNA 和蛋白质评估代谢功能、药物代谢和疾病诱导的测试。根据世界卫生组织（WHO）统计，2020年癌症将导致约1000万人死亡。此外，根据美国癌症协会2021年的统计数据，到2040年，全球癌症负担预计将增至2750万新发病例和1630万癌症患者。如此高的数字表明，据估计癌症发病率不断上升，对原始诊断和预防性治疗的需求不断增加。诊断癌症的方法有很多种，包括PCR、INAAT和NGS等。其中PCR（聚合酶炼式反应）的概念导致了临床DNA检测的巨大进步。基于 PCR 的方法需要简单的仪器和基础设施，仅利用微量的生物材料，并且与临床常规广泛协调。

虽然PCR的成本很高，但最准确的即时PCR方法（准确率超过99%）是包括韩国在内的许多已开发国家大量使用的方法，而发展中国家则大量采用传统PCR（准确率超过90% ） ，比实时 PCR 更便宜。由于其他选择的价格较高，不发达国家通常使用快速 PCR（准确度为 60 - 70%）。在肿瘤分子诊断领域，NGS 是另一项成长最快的技术。许多公司正在加紧努力，以经济地利用这项技术。例如，2021 年 4 月，Illumina Inc. 宣布与 Kartos Therapeutics 合作，共同开发基于 NGS 的 TP53 伴随诊断，这有助于降低与储存和管理基因组资料相关的成本。

基于技术的洞察分子诊断市场

依技术，分子诊断市场分为聚合酶炼式反应、等温核酸扩增技术、DNA定序与二代定序、DNA微阵列、原位杂交等。 PCR 进一步细分为 RT-PCR、qPCR、多重 PCR 等。 PCR 细分市场在 2022 年占据最大的市场份额，预计在预测期内该细分市场的复合年增长率将达到 12.7% 的最高水平。 PCR主要用于复製核酸链来製备或扩增DNA。热循环仪用于在扩增过程中使 DNA 链变性和退火，并与酶、核苷酸和缓衝液等试剂一起建立新型 DNA。此技术广泛应用于基因功能分析、遗传诊断、DNA克隆、亲子鑑定、传染病检测、法医学等领域。聚合酶炼式反应分为传统PCR、即时PCR和数位PCR。然而，疫情期间持续的技术进步和需求激增将继续推动印度和其他亚太国家对 PCR 检测的需求。结核病、肝炎、流感和严重感染等疾病的持续流行将促进 PoC 分子诊断产业的发展趋势。目前，新型冠状病毒肺炎 (COVID-19) 大流行的爆发将为市场创造利润丰厚的成长空间，因为这种方法对于在没有表现出疾病迹象的个体中检测病毒至关重要。 PCR 精湛的灵敏度、相对简单性和成本效益使 PCR 与其他核酸扩增技术区分开来，巩固了其作为分子实验室中流砥柱的地位。由于PCR技术的不断研究和发展，PCR已成为各种临床和诊断应用或检查不可或缺的工具。因此，它为各种传染病的快速护理点诊断提供了许多机会。例如，F. Hoffmann-La Roche Ltd 持续致力于数位 PCR (dPCR) 技术的进步。 dPCR已将其应用扩展到临床领域，并已成为重要的临床工具。 dPCR 提供超灵敏和绝对的核酸定量，无需参考标准。因此，它为标准化和比较实验室之间的结果提供了更广泛的方面。在大流行爆发期间，Mylab PathoDetect COVID-19 定性PCR 试剂盒是先行者之一，是该国首批获得中央药品标准商业批准的企业之一控制组织（CDSCO）去年。获得批准后，Mylab 与生物技术巨头印度血清研究所和当地公司 AP Globale 合作。 PCR再细分为RT-PCR、qPCR、多重PCR等。分子诊断市场，透过基于购买模式的洞察。

根据产品和服务，分子诊断市场分为检测和试剂盒、仪器以及服务和软体。到 2022 年，检测和试剂盒领域将占据最大的市场份额，预计在预测期内将实现市场上最高的复合年增长率。分子诊断分析是广泛使用的分析技术之一。快速分子检测、逆转录聚合酶链反应 (RT-PCR)、抗原等各种类型的检测用于识别和分析各种疾病，例如流感 COVID 19、结核病等。作为产品创新和业务策略的一部分，市场参与者为不同的检测试剂盒提供诊断试剂盒。区域参与者积极参与与该领域相关的业务发展。例如，2021 年 9 月，Mylab Discovery Solutions 收购了 Sanskritech 的多数股权，Sanskritech 是 Swayam 平台的开发商，Swayam 是一种护理点测试系统，可以在护理点执行约 70 项测试。此外，在新冠病毒大流行中，全球各个市场参与者都透过其区域业务部门提供他们的试剂盒。基于上述因素，预计该部门在预测期内将做出显着贡献。

根据最终用户，分子诊断市场分为医院和诊所、诊断实验室、研究和学术机构等。 2022年，诊断实验室领域占据最大的市场份额。此外，由于各地区各种医疗状况的检测和诊断数量增加，预计该领域的需求在 2022 年至 2030 年期间将以 12.7% 的最快复合年增长率增长。诊断实验室是分子诊断产品和服务的主要用途。它拥有符合监管要求的完善设施。实验室使用所有可能的分子诊断产品和服务。使用不同的仪器、试剂、方法和技术对从患者身上采集的样本进行分析和研究。这些实验室为医院、诊所、家庭护理等提供服务。慢性病、传染病的盛行率不断上升，个别研究人员外包分子诊断活动是预测期内支持该细分市场成长的因素之一。

分子诊断市场：竞争格局与主要发展

Abbott Laboratories、Agilent Technologies Inc.、Thermo Fisher Scientific Inc.、F. Hoffman-La Roche Ltd.、Qiagen NV、bioMerieux SA、Illumnia Inc.、Danaher、Siemens Healthineers AG、Novartis AG 和 TBG Diagnostics Limited 均属于领先公司经营分子诊断市场。

市场参与者正在向市场推出新产品。下面举几个例子：

2023 年 1 月，安捷伦将与 Quest Diagnostics 合作，扩大 Agilent Resolution ctDx FIRST 液体活检测试的使用范围。 Quest 和安捷伦之间的协议将使 ctDx FIRST 广泛采用，这是一种在华盛顿 Resolution Bioscience CLIA 实验室进行的单点上市前批准 (ssPMA) 测试。

2023 年 7 月，赛默飞世尔推出了用于分子诊断实验室的新软体。该软体有助于简化常规诊断测试，实现标准化并快速获得结果。它可以透过在单一介面中连接工作流程步骤来增强实验室动态响应快速变化的测试环境的潜力。

2021 年10 月，安捷伦科技公司宣布其Ki-67 IHC MIB-1 pharmDx (Dako Omnis) 现已获得FDA 批准，可用于识别疾病復发高风险的早期乳癌(EBC) 患者，对于这些患者，可以使用佐剂Verzenio (abemaciclib) 与内分泌治疗相结合的治疗。

目录

第 1 章：简介

  • Insight Partners 研究报告指南
  • 市场区隔

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：分子诊断市场格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 欧洲PEST分析
    • 亚太地区 PEST 分析
    • 南美洲和中美洲 PEST 分析
    • 中东和非洲 PEST 分析

第 5 章：分子诊断市场 - 主要产业动态

  • 主要市场驱动因素：
    • 新产品的开发和即时检测需求的增加
    • 相关疾病的盛行率激增
  • 市场限制
    • 与分子测试相关的局限性
  • 市场机会
    • 分子诊断技术的进步
  • 未来的趋势
    • 个性化医疗中的分子诊断
  • 影响分析：

第 6 章：分子诊断市场 - 全球市场分析

  • 分子诊断市场收入，2022 - 2030

第 7 章：全球分子诊断市场 - 2030 年收入与预测 - 按疾病领域

  • 概述
  • 2022 年和 2030 年分子诊断市场收入份额，按疾病领域划分 (%)
  • 肿瘤学
  • 传染病
  • 基因检测
  • 心臟病
  • 免疫系统疾病
  • 其他的

第 8 章：全球分子诊断市场 - 收入与 2030 年预测 - 按技术分类

  • 概述
  • 2022 年和 2030 年按技术分類的分子诊断市场收入份额 (%)
  • 聚合酶炼式反应
  • 等温核酸扩增技术（INAAT）
  • DNA 定序和二代定序 (NGS)
  • DNA微阵列
  • 原位杂交 (ISH)
  • 其他的

第 9 章：全球分子诊断市场 - 收入和 2030 年预测 - 按产品和服务

  • 概述
  • 2022 年和 2030 年分子诊断市场收入份额（按产品和服务划分）（%）
  • 检测方法和试剂盒
  • 仪器
  • 服务和软体

第 10 章：全球分子诊断市场 - 收入和 2030 年预测 - 按最终用户

  • 概述
  • 2022 年和 2030 年分子诊断市场收入份额（按最终用户划分）（%）
  • 医院和诊所
  • 诊断实验室
  • 研究和学术机构
  • 其他的

第 11 章：分子诊断市场 - 地理分析

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 澳洲
    • 韩国
    • 新加坡
    • 马来西亚
    • 菲律宾
    • 泰国
    • 印尼
    • 越南
    • 亚太地区其他地区
  • 中东和非洲
    • 阿联酋
    • 沙乌地阿拉伯
    • 南非
    • 中东和非洲其他地区
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地区

第 12 章：Covid-19 前后的影响

  • Covid-19 前后的影响

第 13 章：分子诊断市场产业格局

  • 概述
  • 市场上公司采取的成长策略（%）
  • 有机发展
    • 概述
  • 无机发展
    • 概述

第 14 章：分子诊断市场，主要公司概况

  • Abbott Laboratories
  • Agilent Technologies Inc
  • Thermo Fisher Scientific Inc
  • F. Hoffmann-La Roche Ltd
  • Qiagen NV
  • bioMerieux SA
  • Illumina Inc
  • Danaher
  • Siemens Healthineers AG
  • Novartis AG
  • TBG Diagnostics Limited

第 15 章：附录

  • 关于我们
  • 专业术语
Product Code: TIPRE00003124

The molecular diagnostics market size is expected to reach US$ 45,875.65 million by 2030 from US$ 18,173.87 million in 2022; it is estimated to register a CAGR of 12.3% from 2022 to 2030. The report highlights trends prevailing in the market and the factors driving and hindering the molecular diagnostics market growth. The growth of the market is attributed to the development of new products and increase in demand for point-of-care testing and surging prevalence of associated diseases. However, limitations associated with molecular testing hinders the market growth.

Molecular Diagnostics in Personalized Medicine for Molecular Diagnostics Market Growth in the Upcoming Years

With progress in high-throughput techniques, genome research has become more convenient and cost effective. Molecular diagnostics is becoming increasingly indispensable in clinical laboratories as these kits and tests provide rapid detection results as opposed to the conventional tests, which also involved culturing microbes in laboratory conditions in some cases. Using precision medicine, medical treatments and interventions are tailored to each patient based on their unique genetic makeup, lifestyle, and environment. Molecular diagnostics plays an important role in this approach, as it enables the identification of specific biomarkers, genetic mutations, and gene expression patterns that impact decision-making related to the treatment of patients. Drug development has become increasingly dependent on molecular diagnostics. A wide range of molecular imaging techniques are used in screening, detecting, diagnosing, treating, and assessing heterogeneity; making progression plans; examining molecular characteristics; and monitoring patient outcomes. In addition, molecular imaging can aid in the detection of tiny tumors and assessment of their activities, contributing significantly to the development and expansion of personalized medicine, research, clinical trials, and medical practice in oncology. A high-throughput genotyping platform can be used to detect genetic aberrations in clinical samples, and next-generation sequencing can be used to identify all types of cancer-causing changes. The introduction of these techniques into clinical practice would enable the identification of molecular targets in each patient, along with facilitating the tracking of the molecular progression of diseases. With these approaches, cancer patients will be able to receive personalized medicine. Thus, with technology ever evolving, the market for molecular diagnostics seems to have a bright future.

Limitations Associated with Molecular Testing Hampers the Market Growth

The outcomes of molecular testing depend on sampling and testing processes, technicians' skill sets, etc., which may lead to variations in test results. Further, some test procedures take longer for producing results. Several times, test kits may show false positive or negative results. Thus, uncertainties associated with molecular tests hamper their adoption, especially in diagnostics and treatment of life-threatening diseases. The limited awareness of point-of-care tests, particularly in developing and underdeveloped countries, also hinders the market growth. In addition, the cost of molecular testing for indications such as cancer and viral infections, and the shortage of supplies are hampering the molecular diagnostics market.

Molecular Diagnostics Market, By Disease Area Insights

Based on disease area, the molecular diagnostics market is segmented into oncology, infectious disease, genetic testing, cardiac diseases, immune system disorders, and others.

The infectious disease segment held the largest market share in 2022. However, oncology segment is anticipated to register the highest CAGR of 12.6% during the forecast period. Oncology molecular diagnostics are tests that expose inherited material, proteins, associated molecules and assess metabolic functions, drug metabolism, and disease induction grounded on DNA, RNA, and proteins that deliver oncological information. As stated by World Health Organization (WHO), cancer reckoned for roughly 10 million demises in 2020. Furthermore, as per the 2021 statistics by the American Cancer Society, by 2040, the global burden of carcinoma is anticipated to raise to 27.5 million fresh cases and 16.3 million cancer deceases. Such like high figures denote that the evaluated rising frequency of cancer is chipping into the accelerating requirement for primitive diagnosis and preventive cure. There are numerous methods to diagnose carcinoma comprehending PCR, INAAT, and NGS etc. Among all the conception of PCR (polymerase chain reaction) led to an enormous advancement in clinical DNA testing. PCR-based methodologies demand straightforward instrumentation and infrastructure, exploit only minute quantities of biological material and are extensively harmonious with clinical routine.

Although the cost of PCR is lofty, most accurate real-time PCR approach (with more than 99% accuracy) is the one substantially used in numerous developed countries including Korea, while developing countries substantially exploit the conventional PCR (more than 90% accuracy), which is affordable than real-time PCR. Because of the high prices of the other options, underdeveloped countries generally use Rapid PCR (60 - 70% accuracy). Within the field of oncology molecular diagnostics, NGS is another technology flaunting the loftiest rate of growth. Numerous companies are working intensely to make economic use of this technology. For instance, in April 2021, Illumina Inc. blazoned its partnership with Kartos Therapeutics to co-develop an NGS- Based TP53 Companion Diagnostic, which aided to reduce the costs associated with storing and managing of genomic data.

Molecular Diagnostics Market, By Technology-Based Insights

Based on technology, the molecular diagnostics market is segmented into polymerase chain reaction, isothermal nucleic acid amplification technology, DNA sequencing & Next-Generation sequencing, DNA microarrays, in-situ hybridization, and others. The PCR is further sub segmented into RT-PCR, qPCR, Multiplex PCR, and others. The PCR segment held the largest share of the market in 2022, and the same segment is anticipated to register the highest CAGR of 12.7% in the market during the forecast period. PCR is mainly used to make or amplify DNA by copying the nucleic acid strands. Thermal cyclers are employed to denature and anneal DNA strands during amplification, along with reagents such as enzymes, nucleotides, and buffers to build the novel DNA. This technique is widely used in various application such as functional analysis of genes, diagnosis of hereditary, DNA cloning, paternity testing, detection of infectious diseases, and forensic sciences. Polymerase chain reaction has been classified into traditional PCR, real-time PCR, and digital PCR. However, ongoing technological advances and surging demand amid the pandemic will continue to fuel the need for PCR tests in India as well as other Asia Pacific countries. Consistent prevalence of diseases like tuberculosis, Hepatitis, flu, and serious infections will foster PoC molecular diagnostic industry trends. Presently, the outbreak of novel COVID-19 pandemic would create lucrative growth aspects for the market as this approach is highly critical to detect virus in individuals who exhibit no symptoms of signs of disease. PCR's exquisite sensitivity, relative simplicity, and cost-effectiveness makes PCR stand apart from other nucleic acid amplification techniques, cementing it as a mainstay in molecular laboratories. PCR has become an indispensable tool for various clinical and diagnostic applications or examinations due to continuous research & development on PCR technologies. Therefore, it offers many opportunities for rapid point-of-care diagnostics for various infectious diseases. For instance, F. Hoffmann-La Roche Ltd is continuously working on the advancements of Digital PCR (dPCR) techniques. dPCR has extended its applications to the clinical field and has emerged as an important clinical tool. dPCR offers ultrasensitive and absolute nucleic acid quantification without reference standard. Thus, it offers a broader aspect for standardizing and comparing results between laboratories.During pandemic outbreak, one of the first mover startup, Mylab PathoDetect COVID-19 Qualitative PCR kit was among the first in the country to receive commercial approval from the Central Drugs Standard Control Organisation (CDSCO) last year. Following the approval, Mylab had partnered with biotech giant Serum Institute of India and local firm AP Globale. PCR is further sub-segmented into RT-PCR, qPCR, multiplex PCR and others. Molecular Diagnostics Market, By Purchase Mode-Based Insights.

Based on product & services, the molecular diagnostics market is segmented into assays & kits, instruments, and services & software. The assays and kits segment are held the largest share of the market in 2022, and it is anticipated to register the highest CAGR in the market during the forecast period. Molecular Diagnostics assays are among the widely used technique for analysis. Various types of assays such as rapid molecular assays, reverse transcription-polymerase chain reaction (RT-PCR), antigens, and others are used to identify and analyze various diseases such as influenza COVID 19, tuberculosis, and others. As part of product innovation and business strategies, the market players offer diagnostic kits for different test kits. The regional players are actively involved in business development related to the segment. For instance, In September 2021, Mylab Discovery Solutions acquired a majority stake in Sanskritech, developer of a platform Swayam a point of care testing system that can perform about 70 tests on the point. Moreover, in the COVID19 pandemic, various global market players offer their kits through their regional business divisions. Based on the above factors, the segment is expected to contribute remarkably during the forecast period.

Based on end user, the molecular diagnostics market is segmented into hospitals & clinics, diagnostic laboratories, research & academic institutions, and others. In 2022, the diagnostic laboratories segment held the largest share of the market. Moreover, the segment is also expected to witness growth in its demand at a fastest CAGR of 12.7% during 2022 to 2030, owing to the rise in the detection and diagnosis of various medical conditions across the regions. Diagnostic laboratories are the primary uses for molecular diagnostics products and services. It has well-established facilities as per the regulatory requirements. The laboratories use all possible molecular diagnostic products and services. The sample collected from the patients is analyzed and studied using different instruments, reagents, methods, and technologies. The labs provide services to hospitals, clinics, at-home care, and others. The increasing prevalence of chronic diseases, infectious diseases, outsourcing the molecular diagnostics activities by individual researchers are among the factors supporting the segment growth during the forecast period.

Molecular Diagnostics Market: Competitive Landscape and Key Developments

Abbott Laboratories, Agilent Technologies Inc., Thermo Fisher Scientific Inc, F. Hoffman-La Roche Ltd., Qiagen NV, bioMerieux SA, Illumnia Inc., Danaher, Siemens Healthineers AG, Novartis AG, and TBG Diagnostics Limited are among the leading companies operating in the molecular diagnostics market.

Market players are launching new products to the market. Below are few instances:

In January 2023, Agilent to Collaborate with Quest Diagnostics to Extend Access to the Agilent Resolution ctDx FIRST Liquid Biopsy Test. The agreement between Quest and Agilent will enable broad adoption for ctDx FIRST, a single-site premarket approved (ssPMA) test performed at the Resolution Bioscience CLIA laboratory in Washington.

In July 2023, Thermo Fisher launched new software for molecular diagnostics labs. This software helps in streamlining routine diagnostics testing for standardization and rapid time-to-results. It can enhance the potential of a lab to dynamically respond to quickly changing testing environments by connecting workflow steps within a single interface.

In October 2021, Agilent Technologies Inc. has announced its Ki-67 IHC MIB-1 pharmDx (Dako Omnis) is now FDA approved as an aid in identifying patients with early breast cancer (EBC) at high risk of disease recurrence, for whom adjuvant treatment with Verzenio (abemaciclib) in combination with endocrine therapy.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the molecular diagnostics market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Molecular Diagnostics Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis

5. Molecular Diagnostics Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Development of New Products and Increase in Demand for Point-of-Care Testing
    • 5.1.2 Surging Prevalence of Associated Diseases
  • 5.2 Market Restraints
    • 5.2.1 Limitations Associated with Molecular Testing
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Molecular Diagnostics Technologies
  • 5.4 Future Trends
    • 5.4.1 Molecular Diagnostics in Personalized Medicine
  • 5.5 Impact Analysis:

6. Molecular Diagnostics Market - Global Market Analysis

  • 6.1 Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030

7. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Disease Area

  • 7.1 Overview
  • 7.2 Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • 7.3 Oncology
    • 7.3.1 Overview
    • 7.3.2 Oncology: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Infectious Disease
    • 7.4.1 Overview
    • 7.4.2 Infectious Disease: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Genetic Testing
    • 7.5.1 Overview
    • 7.5.2 Genetic Testing: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Cardiac Diseases
    • 7.6.1 Overview
    • 7.6.2 Cardiac Diseases: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Immune System Disorders
    • 7.7.1 Overview
    • 7.7.2 Immune System Disorders: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Others
    • 7.8.1 Overview
    • 7.8.2 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Technology

  • 8.1 Overview
  • 8.2 Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Overview
    • 8.3.2 PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.2.1 RT-PCR
        • 8.3.2.1.1 Overview
    • 8.3.3 RT-PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.3.1 qPCR
        • 8.3.3.1.1 Overview
    • 8.3.4 PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.4.1 Multiplex PCR
        • 8.3.4.1.1 Overview
    • 8.3.5 Multiplex PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
      • 8.3.5.1 Others
        • 8.3.5.1.1 Overview
    • 8.3.6 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
    • 8.4.1 Overview
    • 8.4.2 Isothermal Nucleic Acid Amplification Technology (INAAT): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 DNA Sequencing and Next-Generation Sequencing (NGS)
    • 8.5.1 Overview
    • 8.5.2 DNA Sequencing and Next-Generation Sequencing (NGS): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 DNA Microarrays
    • 8.6.1 Overview
    • 8.6.2 DNA Microarrays: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.7 In-Situ Hybridization (ISH)
    • 8.7.1 Overview
    • 8.7.2 In-Situ Hybridization (ISH): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.8 Others
    • 8.8.1 Overview
    • 8.8.2 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

9. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by Product and Services

  • 9.1 Overview
  • 9.2 Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • 9.3 Assays and Kits
    • 9.3.1 Overview
    • 9.3.2 Assays and Kits: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Instruments
    • 9.4.1 Overview
    • 9.4.2 Instruments: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Services and Software
    • 9.5.1 Overview
    • 9.5.2 Services and Software: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

10. Global Molecular Diagnostics Market - Revenue and Forecast to 2030 - by End User

  • 10.1 Overview
  • 10.2 Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • 10.3 Hospitals and Clinics
    • 10.3.1 Overview
    • 10.3.2 Hospitals and Clinics: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.4 Diagnostics Laboratories
    • 10.4.1 Overview
    • 10.4.2 Diagnostics Laboratories: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.5 Research and Academic Institutes
    • 10.5.1 Overview
    • 10.5.2 Research and Academic Institutes: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)

11. Molecular Diagnostics Market - Geographical Analysis

  • 11.1 North America Molecular Diagnostics Market, Revenue And Forecast To 2030
    • 11.1.1 Overview
    • 11.1.2 North America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.3 North America Molecular Diagnostics Market, by Disease Area
    • 11.1.4 North America Molecular Diagnostics Market, by Technology
      • 11.1.4.1 North America Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
    • 11.1.5 North America Molecular Diagnostics Market, by Product and Services
    • 11.1.6 North America Molecular Diagnostics Market, by End User
      • 11.1.6.1 North America Molecular Diagnostics Market, by Country
    • 11.1.7 US
      • 11.1.7.1 Overview
    • 11.1.8 US Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.9 US Molecular Diagnostics Market, by Disease Area
    • 11.1.10 US Molecular Diagnostics Market, by Technology
      • 11.1.10.1 US Molecular Diagnostics Market, by Polymerase Chain Reaction (PCR)
    • 11.1.11 US Molecular Diagnostics Market, by Product and Services
    • 11.1.12 US Molecular Diagnostics Market, by End User
    • 11.1.13 Canada
      • 11.1.13.1 Overview
    • 11.1.14 Canada Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.15 Canada Molecular Diagnostics Market, by Disease Area
    • 11.1.16 Canada Molecular Diagnostics Market, by Technology
      • 11.1.16.1 Canada Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.17 Canada Molecular Diagnostics Market, by Product and Services
    • 11.1.18 Canada Molecular Diagnostics Market, by End User
    • 11.1.19 Mexico
      • 11.1.19.1 Overview
    • 11.1.20 Mexico Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.1.21 Mexico Molecular Diagnostics Market, by Disease Area
    • 11.1.22 Mexico Molecular Diagnostics Market, by Technology
      • 11.1.22.1 Mexico Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.1.23 Mexico Molecular Diagnostics Market, by Product and Services
    • 11.1.24 Mexico Molecular Diagnostics Market, by End User
  • 11.2 Europe Molecular Diagnostics Market, Revenue And Forecast to 2030
    • 11.2.1 Overview
    • 11.2.2 Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.3 Europe Molecular Diagnostics Market, by Disease Area
    • 11.2.4 Europe Molecular Diagnostics Market, by Technology
      • 11.2.4.1 Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.5 Europe Molecular Diagnostics Market, by Product and Services
    • 11.2.6 Europe Molecular Diagnostics Market, by End User
      • 11.2.6.1 Europe Molecular Diagnostics Market by Country
    • 11.2.7 Germany
      • 11.2.7.1 Overview
    • 11.2.8 Germany Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.9 Germany Molecular Diagnostics Market, by Disease Area
    • 11.2.10 Germany Molecular Diagnostics Market, by Technology
      • 11.2.10.1 Germany Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.11 Germany Molecular Diagnostics Market, by Product and Services
    • 11.2.12 Germany Molecular Diagnostics Market, by End User
    • 11.2.13 UK
      • 11.2.13.1 Overview
    • 11.2.14 UK Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.15 UK Molecular Diagnostics Market, by Disease Area
    • 11.2.16 UK Molecular Diagnostics Market, by Technology
      • 11.2.16.1 UK Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.17 UK Molecular Diagnostics Market, by Product and Services
    • 11.2.18 UK Molecular Diagnostics Market, by End User
    • 11.2.19 France
      • 11.2.19.1 Overview
    • 11.2.20 France Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.21 France Molecular Diagnostics Market, by Disease Area
    • 11.2.22 France Molecular Diagnostics Market, by Technology
      • 11.2.22.1 France Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.23 France Molecular Diagnostics Market, by Product and Services
    • 11.2.24 France Molecular Diagnostics Market, by End User
    • 11.2.25 Italy
      • 11.2.25.1 Overview
    • 11.2.26 Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.27 Italy Molecular Diagnostics Market, by Disease Area
    • 11.2.28 Italy Molecular Diagnostics Market, by Technology
      • 11.2.28.1 Italy Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.29 Italy Molecular Diagnostics Market, by Product and Services
    • 11.2.30 Italy Molecular Diagnostics Market, by End User
    • 11.2.31 Spain
      • 11.2.31.1 Overview
    • 11.2.32 Spain Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.33 Spain Molecular Diagnostics Market, by Disease Area
    • 11.2.34 Spain Molecular Diagnostics Market, by Technology
      • 11.2.34.1 Spain Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
        • 11.2.34.1.1 Spain Molecular Diagnostics Market, by Product and Services
    • 11.2.35 Spain Molecular Diagnostics Market, by End User
    • 11.2.36 Rest of Europe
      • 11.2.36.1 Overview
    • 11.2.37 Rest of Europe Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.2.38 Rest of Europe Molecular Diagnostics Market, by Disease Area
    • 11.2.39 Rest of Europe Molecular Diagnostics Market, by Technology
      • 11.2.39.1 Rest of Europe Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.2.40 Rest of Europe Molecular Diagnostics Market, by Product and Services
    • 11.2.41 Rest of Europe Molecular Diagnostics Market, by End User
  • 11.3 Asia Pacific Molecular Diagnostics Market, Revenue And Forecast to 2030
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.3 Asia Pacific Molecular Diagnostics Market, by Disease Area
    • 11.3.4 Asia Pacific Molecular Diagnostics Market, by Technology
      • 11.3.4.1 Asia Pacific Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.5 Asia Pacific Molecular Diagnostics Market, by Product and Services
    • 11.3.6 Asia Pacific Molecular Diagnostics Market, by End User
      • 11.3.6.1 Asia Pacific Molecular Diagnostics Market by Country
    • 11.3.7 China
      • 11.3.7.1 Overview
    • 11.3.8 China Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.9 China Molecular Diagnostics Market, by Disease Area
    • 11.3.10 China Molecular Diagnostics Market, by Technology
      • 11.3.10.1 China Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.11 China Molecular Diagnostics Market, by Product and Services
    • 11.3.12 China Molecular Diagnostics Market, by End User
    • 11.3.13 Japan
      • 11.3.13.1 Overview
    • 11.3.14 Japan Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.15 Japan Molecular Diagnostics Market, by Disease Area
    • 11.3.16 Japan Molecular Diagnostics Market, by Technology
      • 11.3.16.1 Japan Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.17 Japan Molecular Diagnostics Market, by Product and Services
    • 11.3.18 Japan Molecular Diagnostics Market, by End User
    • 11.3.19 India
      • 11.3.19.1 Overview
    • 11.3.20 India Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.21 India Molecular Diagnostics Market, by Disease Area
    • 11.3.22 India Molecular Diagnostics Market, by Technology
      • 11.3.22.1 India Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.23 India Molecular Diagnostics Market, by Product and Services
    • 11.3.24 India Molecular Diagnostics Market, by End User
    • 11.3.25 Australia
      • 11.3.25.1 Overview
    • 11.3.26 Australia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.27 Australia Molecular Diagnostics Market, by Disease Area
    • 11.3.28 Australia Molecular Diagnostics Market, by Technology
      • 11.3.28.1 Australia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.29 Australia Molecular Diagnostics Market, by Product and Services
    • 11.3.30 Australia Molecular Diagnostics Market, by End User
    • 11.3.31 South Korea
      • 11.3.31.1 Overview
    • 11.3.32 South Korea Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.33 South Korea Molecular Diagnostics Market, by Disease Area
    • 11.3.34 South Korea Molecular Diagnostics Market, by Technology
      • 11.3.34.1 South Korea Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.35 South Korea Molecular Diagnostics Market, by Product and Services
    • 11.3.36 South Korea Molecular Diagnostics Market, by End User
    • 11.3.37 Singapore
      • 11.3.37.1 Overview
    • 11.3.38 Singapore Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.39 Singapore Molecular Diagnostics Market, by Disease Area
    • 11.3.40 Singapore Molecular Diagnostics Market, by Technology
      • 11.3.40.1 Singapore Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.41 Singapore Molecular Diagnostics Market, by Product and Services
    • 11.3.42 Singapore Molecular Diagnostics Market, by End User
    • 11.3.43 Malaysia
      • 11.3.43.1 Overview
    • 11.3.44 Malaysia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.45 Malaysia Molecular Diagnostics Market, by Disease Area
    • 11.3.46 Malaysia Molecular Diagnostics Market, by Technology
      • 11.3.46.1 Malaysia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.47 Malaysia Molecular Diagnostics Market, by Product and Services
    • 11.3.48 Malaysia Molecular Diagnostics Market, by End User
    • 11.3.49 Philippines
      • 11.3.49.1 Overview
    • 11.3.50 Philippines Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.51 Philippines Molecular Diagnostics Market, by Disease Area
    • 11.3.52 Philippines Molecular Diagnostics Market, by Technology
      • 11.3.52.1 Philippines Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.53 Philippines Molecular Diagnostics Market, by Product and Services
    • 11.3.54 Philippines Molecular Diagnostics Market, by End User
    • 11.3.55 Thailand
      • 11.3.55.1 Overview
    • 11.3.56 Thailand Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.57 Thailand Molecular Diagnostics Market, by Disease Area
    • 11.3.58 Thailand Molecular Diagnostics Market, by Technology
      • 11.3.58.1 Thailand Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.59 Thailand Molecular Diagnostics Market, by Product and Services
    • 11.3.60 Thailand Molecular Diagnostics Market, by End User
    • 11.3.61 Indonesia
      • 11.3.61.1 Overview
    • 11.3.62 Indonesia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.63 Indonesia Molecular Diagnostics Market, by Disease Area
    • 11.3.64 Indonesia Molecular Diagnostics Market, by Technology
      • 11.3.64.1 Indonesia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.65 Indonesia Molecular Diagnostics Market, by Product and Services
    • 11.3.66 Indonesia Molecular Diagnostics Market, by End User
    • 11.3.67 Vietnam
      • 11.3.67.1 Overview
    • 11.3.68 Vietnam Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.69 Vietnam Molecular Diagnostics Market, by Disease Area
    • 11.3.70 Vietnam Molecular Diagnostics Market, by Technology
      • 11.3.70.1 Vietnam Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.71 Vietnam Molecular Diagnostics Market, by Product and Services
    • 11.3.72 Vietnam Molecular Diagnostics Market, by End User
    • 11.3.73 Rest of Asia Pacific
      • 11.3.73.1 Overview
    • 11.3.74 Rest of Asia Pacific Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.3.75 Rest of Asia Pacific Molecular Diagnostics Market, by Disease Area
    • 11.3.76 Rest of Asia Pacific Molecular Diagnostics Market, by Technology
      • 11.3.76.1 Rest of Asia Pacific Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.3.77 Rest of Asia Pacific Molecular Diagnostics Market, by Product and Services
    • 11.3.78 Rest of Asia Pacific Molecular Diagnostics Market, by End User
  • 11.4 Middle East & Africa Molecular Diagnostics Market, Revenue And Forecast to 2030
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.3 Middle East & Africa Molecular Diagnostics Market, by Disease Area
    • 11.4.4 Middle East & Africa Molecular Diagnostics Market, by Technology
      • 11.4.4.1 Middle East & Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.4.5 Middle East & Africa Molecular Diagnostics Market, by Product and Services
    • 11.4.6 Middle East & Africa Molecular Diagnostics Market, by End User
      • 11.4.6.1 Middle East & Africa Molecular Diagnostics Market by Country
    • 11.4.7 UAE
      • 11.4.7.1 Overview
    • 11.4.8 UAE Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.9 UAE Molecular Diagnostics Market, by Disease Area
    • 11.4.10 UAE Molecular Diagnostics Market, by Technology
      • 11.4.10.1 UAE Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.4.11 UAE Molecular Diagnostics Market, by Product and Services
    • 11.4.12 UAE Molecular Diagnostics Market, by End User
    • 11.4.13 Saudi Arabia
      • 11.4.13.1 Overview
    • 11.4.14 Saudi Arabia Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.15 Saudi Arabia Molecular Diagnostics Market, by Disease Area
    • 11.4.16 Saudi Arabia Molecular Diagnostics Market, by Technology
      • 11.4.16.1 Saudi Arabia Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.4.17 Saudi Arabia Molecular Diagnostics Market, by Product and Services
    • 11.4.18 Saudi Arabia Molecular Diagnostics Market, by End User
    • 11.4.19 South Africa
      • 11.4.19.1 Overview
    • 11.4.20 South Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.21 South Africa Molecular Diagnostics Market, by Disease Area
    • 11.4.22 South Africa Molecular Diagnostics Market, by Technology
      • 11.4.22.1 South Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.4.23 South Africa Molecular Diagnostics Market, by Product and Services
    • 11.4.24 South Africa Molecular Diagnostics Market, by End User
    • 11.4.25 Rest of Middle East & Africa
      • 11.4.25.1 Overview
    • 11.4.26 Rest of Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.4.27 Rest of Middle East & Africa Molecular Diagnostics Market, by Disease Area
    • 11.4.28 Rest of Middle East & Africa Molecular Diagnostics Market, by Technology
      • 11.4.28.1 Rest of Middle East & Africa Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.4.29 Rest of Middle East & Africa Molecular Diagnostics Market, by Product and Services
    • 11.4.30 Rest of Middle East & Africa Molecular Diagnostics Market, by End User
  • 11.5 South & Central America Molecular Diagnostics Market, Revenue And Forecast to 2030
    • 11.5.1 Overview
    • 11.5.2 South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.3 South & Central America Molecular Diagnostics Market, by Disease Area
    • 11.5.4 South & Central America Molecular Diagnostics Market, by Technology
      • 11.5.4.1 South & Central America Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.5.5 South & Central America Molecular Diagnostics Market, by Product and Services
    • 11.5.6 South & Central America Molecular Diagnostics Market, by End User
      • 11.5.6.1 South & Central America Molecular Diagnostics Market by Country
    • 11.5.7 Brazil
      • 11.5.7.1 Overview
    • 11.5.8 Brazil Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.9 Brazil Molecular Diagnostics Market, by Disease Area
    • 11.5.10 Brazil Molecular Diagnostics Market, by Technology
      • 11.5.10.1 Brazil Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.5.11 Brazil Molecular Diagnostics Market, by Product and Services
    • 11.5.12 Brazil Molecular Diagnostics Market, by End User
    • 11.5.13 Argentina
      • 11.5.13.1 Overview
    • 11.5.14 Argentina Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.15 Argentina Molecular Diagnostics Market, by Disease Area
    • 11.5.16 Argentina Molecular Diagnostics Market, by Technology
      • 11.5.16.1 Argentina Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.5.17 Argentina Molecular Diagnostics Market, by Product and Services
    • 11.5.18 Argentina Molecular Diagnostics Market, by End User
    • 11.5.19 Rest of South & Central America
      • 11.5.19.1 Overview
    • 11.5.20 Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
    • 11.5.21 Rest of South & Central America Molecular Diagnostics Market, by Disease Area
    • 11.5.22 Rest of South & Central America Molecular Diagnostics Market, by Technology
      • 11.5.22.1 Rest of South & Central America Molecular Diagnostics Market, Polymerase Chain Reaction (PCR)
    • 11.5.23 Rest of South & Central America Molecular Diagnostics Market, by Product and Services
    • 11.5.24 Rest of South & Central America Molecular Diagnostics Market, by End User

12. Pre & Post Covid-19 Impact

  • 12.1 Pre & Post Covid-19 Impact

13. Molecular Diagnostics Market Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market (%)
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Molecular Diagnostics Market, Key Company Profiles

  • 14.1 Abbott Laboratories
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Agilent Technologies Inc
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Thermo Fisher Scientific Inc
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 F. Hoffmann-La Roche Ltd
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Qiagen NV
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 bioMerieux SA
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Illumina Inc
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Danaher
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Siemens Healthineers AG
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Novartis AG
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 TBG Diagnostics Limited
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments

15. Appendix

  • 15.1 About Us
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. Molecular Diagnostics Market Segmentation
  • Table 2. North America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 3. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 4. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 5. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 6. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 7. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 8. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 9. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 10. US Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 11. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 12. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 13. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 14. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 15. Canada Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 16. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 17. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 18. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 19. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 20. Mexico Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 21. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 22. Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 23. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 24. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 25. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 26. Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 27. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Disease Area
  • Table 28. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 29. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 30. Germany Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 31. Germany Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 32. UK Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 33. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 34. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 35. UK Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 36. UK Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 37. France Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 38. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 39. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 40. France Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 41. France Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 42. Italy Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 43. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 44. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 45. Italy Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 46. Italy Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 47. Spain Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 48. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 49. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 50. Spain Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 51. Spain Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 52. Rest of Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 53. Rest of Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 54. Rest of Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 55. Rest of Europe Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 56. Rest of Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 57. Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 58. Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 59. Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 60. Asia PAcific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 61. Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 62. China Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 63. China Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 64. China Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 65. North America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 66. China Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 67. Japan Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 68. Japan Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 69. Japan Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 70. Japan Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 71. Japan Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 72. India Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 73. India Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 74. India Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 75. India Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 76. India Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 77. Australia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 78. Australia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 79. Australia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 80. Australia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 81. Australia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 82. South Korea Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 83. South Korea Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 84. South Korea Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 85. South Korea Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 86. South Korea Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 87. Singapore Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 88. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 89. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 90. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 91. Singapore Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 92. Malaysia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 93. Malaysia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 94. Malaysia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 95. Malaysia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 96. Malaysia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 97. Philippines Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 98. Philippines Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 99. Philippines Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 100. Philippines Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 101. Philippines Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 102. Thailand Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 103. Thailand Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 104. Thailand Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 105. Thailand Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 106. Thailand Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 107. Indonesia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 108. Indonesia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 109. Indonesia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 110. Indonesia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 111. Indonesia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 112. Vietnam Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 113. Vietnam Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 114. Vietnam Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 115. Vietnam Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 116. Vietnam Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 117. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 118. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 119. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 120. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 121. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 122. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 123. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 124. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 125. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 126. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 127. UAE Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 128. UAE Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 129. UAE Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 130. UAE Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 131. UAE Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 132. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 133. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 134. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 135. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 136. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 137. South Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 138. South Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 139. South Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 140. South Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 141. South Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 142. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 143. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 144. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 145. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 146. Rest of Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 147. South & Central America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 148. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 149. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 150. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 151. South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - End User
  • Table 152. Brazil Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 153. Brazil Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 154. Brazil Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 155. Brazil Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 156. Brazil Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 157. Argentina Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - Disease Area
  • Table 158. Argentina Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Technology
  • Table 159. Argentina Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 160. Argentina Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 161. Argentina Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 162. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn) - Disease Area
  • Table 163. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Technology
  • Table 164. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast To 2028 (US$ Mn) - Polymerase Chain Reaction (PCR)
  • Table 165. Rest of South & Central America Molecular Diagnostics Market Revenue And Forecast To 2028 (US$ Mn) - Product and Services
  • Table 166. Rest of South & Central America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn) - End User
  • Table 167. Organic Developments Done By Companies
  • Table 168. Inorganic Developments Done By Companies
  • Table 169. Glossary of Terms, Molecular Diagnostics Market

List Of Figures

  • Figure 1. North America - PEST Analysis
  • Figure 2. Europe - PEST Analysis
  • Figure 3. Asia Pacific - PEST Analysis
  • Figure 4. South & Central America - PEST Analysis
  • Figure 5. Middle East & Africa - PEST Analysis
  • Figure 6. Molecular Diagnostics Market - Key Industry Dynamics
  • Figure 7. Impact Analysis of Drivers and Restraints
  • Figure 8. Molecular Diagnostics Market Revenue (US$ Mn), 2022 - 2030
  • Figure 9. Molecular Diagnostics Market Revenue Share, by Disease Area 2022 & 2030 (%)
  • Figure 10. Oncology: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Infectious Disease: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Infectious Disease: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Cardiac Diseases: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Immune System Disorders: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Molecular Diagnostics Market Revenue Share, by Technology 2022 & 2030 (%)
  • Figure 17. PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. RT-PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. qPCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Multiplex PCR: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Isothermal Nucleic Acid Amplification Technology (INAAT): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. DNA Sequencing and Next-Generation Sequencing (NGS): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. DNA microarrays: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. In-Situ Hybridization (ISH): Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Molecular Diagnostics Market Revenue Share, by Product and Services 2022 & 2030 (%)
  • Figure 28. Assays and Kits: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Instruments: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 30. Services and Software: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Molecular Diagnostics Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 32. Hospitals and Clinics: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. Ambulatory Surgical Centers: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Research and Academic Institutes: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Others: Molecular Diagnostics Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Molecular Diagnostics Market, 2022 ($Mn)
  • Figure 37. North America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 38. North America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 39. US Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 40. Canada Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 41. Mexico Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 42. Europe Molecular Diagnostics Market, By Geography, 2022 ($Mn)
  • Figure 43. Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 44. Europe Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 45. Germany Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 46. UK Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 47. France Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 48. Italy Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 49. Spain Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 50. Rest of Europe Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 51. Molecular Diagnostics Market, By Geography, 2022 ($Mn)
  • Figure 52. Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 53. Asia Pacific Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 54. China Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 55. Japan Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 56. India Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 57. Australia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 58. South Korea Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 59. Singapore Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 60. Malaysia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 61. Philippines Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 62. Thailand Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 63. Indonesia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 64. Vietnam Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 65. Rest of Asia Pacific Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 66. Molecular Diagnostics Market, By Geography, 2022 And 2030 ($Mn)
  • Figure 67. Middle East & Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 68. Middle East & Africa Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 69. UAE Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 70. Saudi Arabia Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 71. South Africa Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 72. Rest of Middle East & Africa Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 73. Molecular Diagnostics Market, By Geography, 2022 ($Mn)
  • Figure 74. South & Central America Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 75. South & Central America Molecular Diagnostics Market, By Key Countries, 2022 And 2030 (%)
  • Figure 76. Brazil Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 77. Argentina Molecular Diagnostics Market Revenue And Forecast to 2030 (US$ Mn)
  • Figure 78. Rest of South & Central America Molecular Diagnostics Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 79. Pre & Post Covid-19 Impact
  • Figure 80. Growth Strategies Done by the Companies in the Market (%)